CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 102 enrolled
Drug / intervention
External Beam Radiation Therapy +3 moreradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02699697
NCT02699697N/ACompleted
CompareCT.gov

A Prospective Randomized Phase II Study of 1 vs 2 Fractions of Palliative Radiation Therapy for Patients With Symptomatic Bone Metastasis

Wake Forest University Health Sciences·interventional·Posted Mar 4, 2016·Updated Dec 11, 2025

In Brief

A clinical study evaluating External Beam Radiation Therapy, Palliative Radiation Therapy, and 2 other interventions for Malignant Neoplasm and 2 related conditions. Completed, enrolled 102 participants across 1 site.

Detailed Summary

This randomized phase II trial studies how well palliative radiation therapy works in reducing pain in patients with cancer that has spread from the original (primary) tumor to the bone (bone metastasis). Palliative radiation therapy using external beam radiation therapy may help patients with bone metastasis to relieve symptoms and reduce pain caused by cancer.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMalignant Neoplasm, Metastatic Malignant Neoplasm in the Bone, Pain
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedMar 4, 2016
Enrollment StartMay 1, 2016
Primary CompletionMar 20, 2025
TodayJul 2, 2026
Enrollment to primary: 8.9 yearsPosted 10.3 years ago

Interventions

External Beam Radiation Therapyradiation

Undergo EBRT

Palliative Radiation Therapyradiation

Undergo EBRT

Quality-of-Life Assessmentother

Ancillary studies

Questionnaire Administrationother

Ancillary studies